Iterum Therapeutics plc (ITRMF) Other Working Capital Changes (2017 - 2025)

Iterum Therapeutics has reported Other Working Capital Changes for 9 years, with the latest figure at $984000.0 in Q3 2025.

• On a quarterly basis, Other Working Capital Changes fell 27.22% year-over-year to $984000.0 in Q3 2025; TTM through Sep 2025 was $2.3 million, a 28.69% decrease from a year earlier, with the FY2024 full-year figure at $2.7 million, down 16.47% from the prior year.
• Other Working Capital Changes was $984000.0 for Q3 2025 at Iterum Therapeutics, down from $1.1 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $1.5 million in Q2 2022, with the low at -$3.2 million in Q1 2021.
• Average Other Working Capital Changes over 5 years is $452105.3, with a median of $625000.0 recorded in 2021.
• The largest YoY upside for Other Working Capital Changes was 1030.77% in 2021 against a maximum downside of 437.29% in 2021.
• Over 5 years, Other Working Capital Changes stood at $508000.0 in 2021, then slumped by 137.6% to -$191000.0 in 2022, then surged by 428.8% to $628000.0 in 2023, then tumbled by 85.99% to $88000.0 in 2024, then surged by 1018.18% to $984000.0 in 2025.
• The last three Other Working Capital Changes figures came in at $984000.0 (Q3 2025), $1.1 million (Q2 2025), and $133000.0 (Q1 2025), per Business Quant data.